Sitemap

EU Expects First COVID Vaccine Application In Coming Days

CorD Recommends

Gold Prices Reach Record Highs Amid Central Bank Acquisition Spree

Gold prices have soared to all-time highs,...

Finland Tops Global Happiness Index, Serbia Sees Significant Rise

Finland has been named the happiest country...

Belgrade University Partners with CERN on Future Circular Collider Project

The University of Belgrade has officially become...

Kushner Eyes Balkan Luxury Developments in Serbia and Albania

Jared Kushner, closely related to former U.S....

Scholz Champions Western Balkans’ Path to Membership

German Chancellor Olaf Scholz, in Slovenia, advocated for quickening the EU accession for the Western Balkans, underlining the importance...

Wiener Städtische Insurance company is the winner of Dobročinitelj (Benefactor) award

The company Wiener Städtische Insurance received the Dobročinitelj (Benefactor) award for socially responsible activities implemented during 2021, 2022 and...

CEB Grants €1.3 Billion Loans to Boost Social Sectors in 11 Countries

The Council of Europe Development Bank (CEB) has sanctioned loans totaling €1.3 billion for 11 member countries, including Serbia...

Serbia Advances in Renewable Energy with Pupin Wind Park Financing

In a significant stride towards renewable energy adoption, Serbia has finalized the financial arrangements for the Pupin Wind Park,...

Đedović Handanović: Nuclear Energy in Serbia by 2039 at the Earliest

Nuclear energy in Serbia could become a reality by 2039 at the earliest, should work on the project commence...

The European Medicines Agency did not name the company it expects to file the application. However, EU leaders hope a vaccine will be available before the end of the year.

The first application for marketing approval of a COVID-19 vaccine in the European Union should arrive in the next few days, according to the European Medicines Agency (EMA).

The drug watchdog did not identify the drugmaker expected to file, however partners Pfizer and BioNTEch are the most advanced in the regulatory approval process. A total of three drugmakers have published late-stage trial data for their respective coronavirus vaccine candidates, including US firm Moderna, and a British partnership between AstraZeneca and Oxford University.

The Pfizer-BioNTech collaboration has already applied for approval in the US, and the UK has asked its medical regulator to assess the vaccine.

Researchers on the US-German vaccine should enjoy a speedy approval process, as they have been allowed to submit data in real-time to the EMA, without waiting for studies to conclude.

The EMA earlier acknowledged it was trying “to speed up” the evaluation process, but said it was “ensuring the same high regulatory standards for quality, safety and efficacy” as for any other drug.

EMA told the AFP news agency that it could approve the first COVID-19 vaccines by the end of the year. Many European countries, including France, Spain and Italy, have based their immunization plans on that basis.

German Chancellor Angela Merkel told lawmakers Thursday that a vaccine may become available before the end of the year.

In the US, if the Food and Drug Administration (FDA) approves accelarated rollout, vaccination efforts may start as early as mid-December.

Related

US Pharma Firm Moderna Says Its COVID-19 Vaccine Is 94.5% Effective

Moderna said that Phase 3 stage analysis suggested its coronavirus vaccine could prevent COVID-19. The news comes a week after Pfizer and German drug-maker...

Oxford Covid Vaccine Works In All Ages, Trials Suggest

Covid vaccine being trialled by Oxford University and AstraZeneca offers hope for all age groups One of the world’s leading Covid-19 experimental vaccines produces an...

Vaccination rollout

In China, medical authorities have already begun immunizing high-risk patients. In Russia, two vaccines have been validated for use before the final phase of clinical trials had started.

The candidates that have passed trials all claim more than 90% effiacy, but their results have not yet been backed up by by publication in peer-reviewed journals, which can usually take months.

Price and logistics will also factor in the success of the vaccines. AstraZeneca’s double dose is the cheapest, costing about €2.5 ($3) per dose and requires just a normal fridge temperature. Moderna’s vaccine must be kept at -20 degrees Celsius (-4 Farenheit), while Pfizer’s must be kept at -70C (-94 Farenheit).

Source:  Deutsche Welle

Related Articles

EU Passes Landmark Media Freedom Law

The European Council has adopted a groundbreaking law aimed at safeguarding media freedom, pluralism, and editorial independence within the European Union, the EU Delegation...

Scholz Champions Western Balkans’ Path to Membership

German Chancellor Olaf Scholz, in Slovenia, advocated for quickening the EU accession for the Western Balkans, underlining the importance of reform-driven progress over geopolitical...

Bosnia and Herzegovina Kickstarts EU Membership Talks

Bosnia and Herzegovina has initiated accession negotiations with the European Union, a development hailed as a pivotal advancement for the Balkan country. This move,...

Gold Prices Reach Record Highs Amid Central Bank Acquisition Spree

Gold prices have soared to all-time highs, with experts predicting further increases as central banks globally continue to amass gold in large quantities. According...

Putin Wins Russian Election Decisively

Presidential candidate Vladimir Putin has won 87.26 percent of the vote based on 60 percent of the ballots counted, the Russian Central Election Commission...

New ENEF II Fund to Propel Growth in Western Balkans

The European Bank for Reconstruction and Development (EBRD) has announced the introduction of the Enterprise Expansion Fund II (ENEF II), aimed at fostering the...

European Parliament Passes Groundbreaking AI Law

The European Parliament has adopted the Artificial Intelligence (AI) Act, aiming to safeguard fundamental rights, democracy, the rule of law, and ecological sustainability in...

Mariya Gabriel Endorses Horizon Europe’s Widening Measures to Bridge Research Gap Ahead of Bulgarian Premiership

Mariya Gabriel, set to ascend to Bulgaria's prime ministerial role in March, champions Horizon Europe's Widening measures as a key strategy to address Europe's...